Facebook Twitter RSS Feed

You are here

Healthcare Economics

 - Medical Money

The rise in healthcare expenditures, particularly in the case of Medicare spending, since 1990 is primarily due to rising treatment prevalence, representing a shift from pre-1990 growth that was spurred by growing incomes, spreading insurance coverage and technological change, according to a study published in the May issue of Health Affairs.

 - breaking the bank, money

To paraphrase Mark Twain, the reports of out-of-control healthcare spending growth are greatly exaggerated. That’s the conclusion reached by an analysis of financial trends published in the May issue of Health Affairs that found public healthcare spending over the next decade could be as much as $770 billion less than predicted.

 - road, split, pathway, two minds

Coverage with evidence development, a provisional reimbursement strategy that provides coverage for promising new technologies under the condition that providers collect clinical data, has been touted as a strategy to boost clinical evidence and curb unnecessary healthcare costs. However, much room for improvement remains, and was outlined in a viewpoint published May 6 in JAMA Internal Medicine.

 - pharmaceutical, money

As price tags for recently FDA-approved drugs to treat chronic myelogenous leukemia (CML) have soared past the $100, 000 level, a group of more than 100 oncologists have characterized the price tags as “too high and unsustainable,” and argued that prices may impede needy patients’ access to treatment and threaten the sustainability of healthcare systems in an article published online April 25 in Blood.

 - Banner Heart Hospital

The end of fee for service will soon rank with death and taxes. Certain. As the countdown begins, how can hospitals start the migration to more accountable, high-quality and appropriate care and protect profits in 2013’s intensely competitive environment? Start right now, advises Banner Heart Hospital CMO Mark Starling, MD.